SCHEMBL805357

SCHEMBL805357

C=C(O)c1ccncc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 12/20 0.39
KDM6B O15054 5/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4D Q6B0I6 3/20 0.39
MAPT P10636 2/20 0.39
KDM4A O75164 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.39
THRB P10828 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CCNC P24863 2/20 0.37
CDK8 P49336 2/20 0.37
AXL P30530 1/20 0.34
SLC6A9 P48067 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526501 0.81 CCNC (0.36) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL29920601 0.78 KDM4C (0.59) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL480991 0.78 KDM4C (0.59) KDM4CKDM6BKDM4EALDH1A1KDM4D
Hydrochloric Acid SCHEMBL2892062 0.77 KDM4C (0.57) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL25207609 0.77 CCNC (0.43) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL19381848 0.74 TDP1 (0.42) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL17425264 0.74 LOXL2 (0.41) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL11341427 0.72 CYP2A6 (0.47) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL5700120 0.72 TDP1 (0.55) KDM4CKDM6BKDM4EALDH1A1KDM4D
SCHEMBL16897000 0.72 CCNC (0.43) KDM4CKDM6BKDM4EALDH1A1KDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071514-A1 BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071514-A1 BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS CYP11B2, CYP11B1, CYP21A2 KDM4C 3010/4885KDM6B 2827/4885KDM4E 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.